DMM Mining Labo

DMM Mining Labo was a healthcare-focused business unit of the Japanese conglomerate DMM.com that specialized in human microbiome analysis. Launched in 2018, the company provided a service for analyzing intestinal flora using next-generation sequencing (NGS) and bioinformatics to offer personalized health and dietary insights. The service translated complex genetic data into user-friendly reports that included dietary advice and health risk assessments for individual consumers. While it aimed to leverage DMM's large-scale data processing expertise in the biotechnology sector, the specific Mining Labo service was discontinued in early 2020. During its operation, it represented a significant attempt by a major technology firm to enter the preventive medicine and genomics market in Japan.